imidapril hydrochloride
CLINICAL USE
Angiotensin-converting enzyme inhibitor:Hypertension
DOSE IN NORMAL RENAL FUNCTION
2.5–20 mg once daily
PHARMACOKINETICS
DOSE IN RENAL IMPAIRMENT
GFR (mL/MIN)
DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugs
ADMINISTRATION
Reconstition
–
Route
Oral
Rate of Administration
–
Comments
–
OTHER INFORMATION
Imidapril is a prodrug, rapidly converted to the active imidaprilatHyperkalaemia and other side effects are more common in patients with impaired renal functionClose monitoring of renal function during therapy is necessary in those with renal insufficiencyRenal failure has been reported in association with ACE inhibitors with renal artery stenosis, post renal transplant or congestive heat failureHigh incidence of anaphylactoid reactions have been reported in patients dialysed with high-flux polyacrylonitrile membranes and treated concomitantly with an ACE inhibitor – combination should therefore be avoided